Pharmacological approaches to treating addiction are evolving rapidly, with growing evidence supporting the efficacy of medication-assisted interventions for diverse substances. Pharmacotherapy and medication-assisted treatment have transformed recovery trajectories for individuals struggling with opioids, alcohol, and even nicotine. Agents like buprenorphine, methadone, and naltrexone help mitigate withdrawal symptoms and reduce cravings while stabilizing long-term outcomes. Integration of behavioral support enhances the efficacy of these medications, providing a more comprehensive care pathway. Clinicians now focus on individualized treatment planning, ensuring the right pharmacological support is matched with the patient's physiological and psychological needs. As stigma diminishes, accessibility and adherence rates continue to improve.
Title : The storm within: Neuropsychological insights into dysregulation and substance use in the adolescent brain
Ann Marie Leonard Zabel, Curry College and NEALAC Clinic , United States
Title : The effect of Balint training on self-efficacy and empathy among medical students and the moderator role of personality traits and choice of specialty
Meni Koslowsky, Ariel University, Israel
Title : Sexualizing anxiety and anxiolytic sex: Misattribution of arousal
Sam Vaknin, Commonwealth Institute of Advanced Professional Studies, United Kingdom
Title : Dr Jekyll and Mr. Hyde revealed: Tales from the default mode network
Christopher Ashton, TeDDs on Chapel, Centre for Recovery, Canada
Title : Integrating bibliopoetry therapy and digital health technologies for inflammation management: A neuropsychosomatic perspective
Nile Stanley, University of North Florida, United States
Title : Addiction and the failure of meaning-forming
Jenni Guentcheva, GoodNeighbor LLC, United States